Updates are available Correction dated 2025-10-09
Click to view Correction: https://doi.org/10.1038/s41467-025-64919-5
-
Authors
Apfelbaum, April A. https://orcid.org/0000-0002-3551-4429
Morin, Eric
Sturm, Dominik https://orcid.org/0000-0003-0250-1696
Ayoub, Georges https://orcid.org/0000-0002-1694-6779
DiGiacomo, Jeromy
Bahadur, Sher
Chandarana, Bhavyaa https://orcid.org/0009-0002-7972-2892
Power, Phoebe C.
Cusick, Margaret M.
Novikov, Dana https://orcid.org/0000-0002-1388-9270
Prabhakar, Prem
Jones, Robert E.
Vogelzang, Jayne
Bossi, Connor C.
Malinowski, Seth
Woodward, Lewis M.
Jones, Tania A. https://orcid.org/0000-0002-0067-3382
Jeang, John
Lamson, Sarah W.
Collins, Jared https://orcid.org/0009-0006-7184-3875
Cai, Kelly Y. https://orcid.org/0009-0001-2556-4844
Jones, Jacquelyn S.
Oh, Sehee
Jeon, Hyesung https://orcid.org/0000-0002-0034-5469
Wang, Jinhua https://orcid.org/0000-0002-1214-4103
Cameron, Amy
Rechter, Patrick https://orcid.org/0009-0009-5160-2996
De Leon, Angela
Murugesan, Karthikeyan https://orcid.org/0000-0002-2275-1126
Montesion, Meagan https://orcid.org/0000-0001-9155-556X
Albacker, Lee A. https://orcid.org/0000-0002-5070-1783
Ramkissoon, Shakti H.
van Tilburg, Cornelis M. https://orcid.org/0000-0001-5274-910X
Hardin, Emily C.
Sievers, Philipp https://orcid.org/0000-0003-3237-6021
Sahm, Felix https://orcid.org/0000-0001-5441-1962
Yeo, Kee Kiat https://orcid.org/0000-0003-0713-6384
Rosenberg, Tom https://orcid.org/0000-0002-9592-2539
Chi, Susan N. https://orcid.org/0000-0001-7753-878X
Wright, Karen D.
Hébert, Steven https://orcid.org/0000-0001-6267-8595
Peck, Sydney
Picca, Alberto https://orcid.org/0000-0001-7807-5393
Larouche, Valérie https://orcid.org/0000-0003-4082-7267
Renzi, Samuele
Buhrlage, Sara J. https://orcid.org/0000-0003-4562-1823
Bale, Tejus A.
Smith, Amy A.
Touat, Mehdi https://orcid.org/0000-0002-5910-7799
Jabado, Nada https://orcid.org/0000-0003-2485-3692
Fischer, Eric S. https://orcid.org/0000-0001-7337-6306
Eck, Michael J.
Baird, Lissa
Witt, Olaf https://orcid.org/0000-0003-3918-9157
Kleinman, Claudia L. https://orcid.org/0000-0002-5158-7126
Nguyen, Quang-De
Sheer, Denise https://orcid.org/0000-0001-9067-1796
Alexandrescu, Sanda
Jones, David T. W. https://orcid.org/0000-0002-2036-5141
Ligon, Keith L. https://orcid.org/0000-0002-7733-600X
Bandopadhayay, Pratiti https://orcid.org/0000-0002-4175-4760
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 3 July 2025
First Online: 31 July 2025
Change Date: 9 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-64919-5
Competing interests
: P.B. serves on paid advisory boards for DayOne Biopharmaceuticals and has served on a paid advisory board for QED Therapeutics. Her lab has received grant funding from Novartis Institute of Biomedical Research. SHR has employment at Labcorp Oncology. C.M.V.T. is on advisory boards for Alexion, Bayer, Novartis, and Roche and has received travel support from Eli Lilly. J.W. is a consultant and equity holder for Soltego. F.S. and D.T.W.J. are co-founders and shareholders of Heidelberg Epignostix GmbH. O.W. is advisory board member or has received research grants from Janssen, Day One Biopharmaceuticals, and Novartis. K.L.L. disclosures: Equity: Travera Inc.; Consulting- Travera Inc., B.M.S., Servier, L.E.K., Integragen, Blaze Bioscience; Research. Research Funding to DFCI: B.M.S. K.M., M.M., L.A.A. are employees of Foundation Medicine, Inc. and stockholders of Roche Holdings AG. E.S.F. is a founder, scientific advisory board (SAB) member, and equity holder of Civetta Therapeutics, Proximity Therapeutics, Neomorph, Inc. (also board of directors), Stelexis Biosciences, Inc., Anvia Therapeutics, Inc., and CPD4, Inc. (also board of directors). He is an equity holder and SAB member for Avilar Therapeutics, Photys Therapeutics, and Ajax Therapeutics, and an equity holder in Lighthorse Therapeutics. E.S.F. is a consultant to Novartis, EcoR1 capital, Odyssey, and Deerfield. The Fischer lab receives or has received research funding from Deerfield, Novartis, Ajax, Interline, Bayer, and Astellas. The Eck lab has received sponsored research support from Novartis, and MJE is a consultant for Syndax Pharmaceuticals. The remaining authors declare no competing interests.
